CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.
Source: Bioprocess Online
Controlling the cost of personalized medicine: We go behind the scenes of the effort to build a system that simplifies production and reduces the cost of non-viral T cell therapies with Ziopharm Oncology CEO Laurence Cooper, M.D., Ph.D.
This website uses cookies to ensure you get the best experience on our website. Learn more